A carregar...
17.1 A RANDOMIZED CONTROLLED TRIAL OF CANNABIDIOL IN SCHIZOPHRENIA
BACKGROUND: Both preclinical and human research suggest that cannabidiol (CBD) has antipsychotic properties. This study assessed the safety and effectiveness of CBD in patients with schizophrenia. METHODS: Patients with schizophrenia (n=88) were randomized to receive CBD (1000 mg/day) or placebo alo...
Na minha lista:
| Publicado no: | Schizophr Bull |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5887970/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby014.065 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|